🟢 NeOnc Technologies Holdings is trading 5% up, with narrower Q3 loss in focus

NeOnc Technologies Holdings is trading at $3.37, up +5.31%, with its November 5 report highlighting a 49% narrower Q3 net loss.

• The report also referenced positive NEO100 Phase 2a results previously reported in August; no new November 6 announcement was identified.
• The biotech sector gained 2.01%, alongside positive broader-market sentiment; both may be contributing, though no direct attribution was reported.
• NEO100 and NEO212 data presentations are scheduled for November 13.